What Is OCD?
Obsessive-compulsive disorder (OCD) is a chronic psychiatric condition defined by two core features: obsessions and compulsions. Obsessions are intrusive, unwanted thoughts, images, or urges that cause significant distress. Compulsions are repetitive behaviours or mental acts performed in an attempt to neutralise that distress. A person who fears contamination may wash their hands until the skin cracks; someone tormented by doubts about the door lock may check it dozens of times before leaving home.
OCD affects roughly 2% to 3% of the global population, making it one of the twenty leading causes of disability worldwide according to the World Health Organization[1]. It typically emerges during one of two peak periods: late childhood (around age 10 to 12) or early adulthood (around age 20 to 25). Men and women are affected in roughly equal numbers, although the childhood-onset subtype is more common in boys.
Causes and Brain Mechanisms
OCD is not a personality flaw or a sign of excessive tidiness. Decades of neuroimaging and molecular research have mapped out a clear neurobiological model.
The CSTC Circuit
The prevailing neuroanatomical model centres on the cortico-striato-thalamo-cortical (CSTC) circuit[2]. In a healthy brain, this loop filters out irrelevant thoughts and suppresses unnecessary actions. In OCD, the braking mechanism within this circuit weakens, allowing specific thought patterns and behaviours to cycle repeatedly.
Functional MRI studies consistently show abnormal activity in the following regions during inhibitory tasks:
Brain Regions and Neurotransmitters Implicated in OCD
| Brain Region | Normal Function | Abnormality in OCD |
|---|---|---|
| Orbitofrontal cortex (OFC) | Threat evaluation, decision-making | Hyperactive, continuously signalling danger |
| Caudate nucleus | Gating of habits and motor sequences | Reduced filtering, allowing irrelevant signals through |
| Anterior cingulate cortex (ACC) | Error detection, conflict monitoring | Hypersensitive, generating persistent "something is wrong" feelings |
| Thalamus | Sensory relay station | Inhibitory gate failure, perpetuating the loop |
Neurotransmitters
Serotonin is the most strongly implicated neurotransmitter. SSRIs (selective serotonin reuptake inhibitors) are effective for OCD, and the doses required are typically higher than those used for depression[3]. This dose-response relationship is itself indirect evidence of serotonin's central role in the disorder.
Dopamine also plays a supporting role. In patients who respond poorly to SSRIs alone, low-dose antipsychotic augmentation (which modulates dopamine) can sometimes produce additional improvement.
Glutamate has attracted growing attention. Studies have found elevated glutamate concentrations in the striatum of OCD patients, and some researchers consider this direct evidence of CSTC circuit hyperactivity. Glutamate-targeted medications remain in clinical trials.
Genetics and Environment
Twin studies estimate the heritability of OCD at approximately 40% to 65%[1]. Having a first-degree relative with OCD raises one's own risk by roughly four to six times. However, genes are not destiny. Stressful life events, major transitions, and in some cases post-infectious immune responses can trigger or worsen symptoms.
Common Symptoms
The content of obsessions and compulsions varies widely, but several themes appear frequently in clinical practice:
- Contamination and cleaning: fear of germs or dirt, excessive handwashing, avoidance of public spaces
- Checking: repeatedly verifying locks, stoves, or car doors, often returning after leaving
- Symmetry and ordering: needing objects in a precise arrangement, feeling intense discomfort when they are not
- Intrusive thoughts: unwanted images of violence, blasphemy, or sexual content that directly contradict the person's values, causing extreme distress
- Hoarding: inability to discard items despite recognising they have no practical use
Most patients are fully aware that their thoughts are irrational, yet they cannot stop acting on them. This tension between insight and compulsion is the hallmark frustration of OCD. In my clinic, many patients preface their first disclosure with: "Doctor, does this mean I'm crazy?" It does not. OCD is a condition with a well-characterised neural circuit basis, and it responds to treatment.
Treatment
Medication
SSRIs are the first-line pharmacological treatment for OCD. A Cochrane systematic review of 17 randomised controlled trials confirmed that SSRIs significantly outperform placebo in reducing obsessive-compulsive symptoms[3]. Commonly prescribed SSRIs include:
- Fluvoxamine
- Fluoxetine
- Sertraline
- Paroxetine
Unlike depression treatment, OCD generally requires higher SSRI doses (for example, Fluoxetine 60 to 80 mg daily, Sertraline 150 to 200 mg daily) and a longer time to onset of response, typically 8 to 12 weeks. If the first SSRI proves insufficient, switching to another SSRI or considering the tricyclic antidepressant Clomipramine are standard next steps. Clomipramine has robust evidence for OCD efficacy but carries more side effects and is usually reserved as a second-line option.
Treatment should be maintained for at least 12 to 24 months before discussing gradual tapering with your psychiatrist. Premature discontinuation is associated with high relapse rates.
Psychotherapy: Exposure and Response Prevention
Exposure and Response Prevention (ERP) is the gold-standard psychotherapy for OCD[4]. During ERP, a therapist guides the patient to deliberately confront anxiety-provoking stimuli (exposure) while refraining from performing the usual compulsive behaviour (response prevention). For someone who washes their hands compulsively, this might mean touching a doorknob and then sitting with the resulting anxiety without washing.
Meta-analyses show that ERP produces 50% to 70% symptom improvement, and its effects are more durable than medication alone after treatment ends[5]. Cognitive behavioural therapy (CBT) techniques are often integrated to help patients identify and challenge catastrophic automatic thoughts, but the behavioural exposure component is the primary engine of therapeutic change.
International treatment guidelines recommend combining SSRIs with ERP for moderate to severe OCD[6].
rTMS (Repetitive Transcranial Magnetic Stimulation)
Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive brain stimulation therapy. In 2018, the US FDA cleared deep TMS for treatment-resistant OCD, targeting the medial prefrontal cortex (mPFC) and anterior cingulate cortex (ACC)[7].
A multicentre randomised controlled trial found that 38.1% of patients receiving active deep TMS achieved clinically meaningful symptom reduction, compared with 11.1% in the sham group[7]. A typical course involves daily sessions over six weeks. rTMS does not require anaesthesia and does not impair cognitive function, making it a viable option for patients who have not responded adequately to two or more SSRI trials.
Self-Screening
If you suspect you may have OCD symptoms, the Generalised Anxiety Disorder scale (GAD-7) can serve as a preliminary anxiety screen. While it does not diagnose OCD directly, it can help you gauge your current anxiety severity and decide whether to seek further evaluation.
Go to online self-assessment tools
If your score falls in the moderate or above range, or if you are spending more than an hour each day on obsessive thoughts and rituals, scheduling an appointment with a psychiatrist is strongly recommended.
When to Seek Help
On average, people with OCD wait seven to ten years before seeking treatment. Any of the following is a good reason to consult a professional:
- Obsessive thoughts or compulsive behaviours occupy more than one hour per day
- You recognise that the thoughts are irrational, yet you cannot stop acting on them through willpower alone
- You have begun avoiding places or situations to prevent triggering anxiety
- Relationships, work performance, or academic results have been affected
- Repetitive behaviours have caused physical harm, such as skin damage from excessive washing
OCD is highly treatable. The earlier the intervention, the greater the brain's plasticity and the better the treatment response.
References
- Stein DJ, Costa DLC, Lochner C, et al. Obsessive-compulsive disorder. Nat Rev Dis Primers. 2019;5:52. DOI PubMed
- Milad MR, Rauch SL. Obsessive-compulsive disorder: beyond segregated cortico-striatal pathways. Trends Cogn Sci. 2012;16(1):43-51. DOI PubMed
- Soomro GM, Altman DG, Rajagopal S, Oakley-Browne M. Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD). Cochrane Database Syst Rev. 2008;(1):CD001765. DOI PubMed
- National Institute for Health and Care Excellence (NICE). Obsessive-compulsive disorder and body dysmorphic disorder: treatment. Clinical guideline CG31. London: NICE; 2005 (updated 2019). NICE
- Olatunji BO, Davis ML, Powers MB, Smits JAJ. Cognitive-behavioral therapy for obsessive-compulsive disorder: a meta-analysis of treatment outcome and moderators. J Psychiatr Res. 2013;47(1):33-41. DOI PubMed
- Koran LM, Hanna GL, Hollander E, Nestadt G, Simpson HB. Practice guideline for the treatment of patients with obsessive-compulsive disorder. Am J Psychiatry. 2007;164(7 Suppl):5-53. PubMed
- Carmi L, Tendler A, Bystritsky A, et al. Efficacy and safety of deep transcranial magnetic stimulation for obsessive-compulsive disorder: a prospective multicenter randomized double-blind placebo-controlled trial. Am J Psychiatry. 2019;176(11):931-938. DOI PubMed
Book an Appointment with Dr. Tam
Attending psychiatrist at Zhongli Tiancheng Hospital and Tianxiang Hospital. Consultations in English, Mandarin, and Cantonese.
Book Now